Back to results
US 2007/0190058 A1Published application
Method for treating intraocular neovascular diseases
AssigneeGenentech, Inc.
InventorNaveed Shams
Life of this patent
Estimating the term…
Abstract
A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically effective amount of VEGF antagonist.
Claims21
A method for treating wet form age-related macular degeneration in a mammal, comprising the steps of:
- a) administering to the mammal a number of first individual doses of an VEGF antagonist;
- and
- b) administering to the mammal a number of second individual doses of the VEGF antagonist, wherein the second individual doses are administered less frequently than the first individual doses.
A method for treating intraocular neovascular disease, comprising:
- administering to a mammal a number of first individual doses of an VEGF antagonist;
- followed by,
- administering to the mammal a number of second individual doses of the antagonist, wherein the second individual doses are administered less frequently than the first individual doses.
Dependencies are inferred from the claim text.